Results 31 to 40 of about 4,299 (147)

Evaluation of red cell distribution width-to-platelet ratio and other laboratory markers in staging Fontan-associated liver disease [PDF]

Polish Journal of Thoracic and Cardiovascular Surgery
Paweł Skorek, Beata Róg, Natalia Bajorek, Tadeusz Wilkosz, Lidia Tomkiewicz-Pająk   +4 more
doaj   +2 more sources

Cross-sectional assessment of haemostatic profile and hepatic dysfunction in Fontan patients

Open Heart, 2021
Background Fontan-associated liver disease is accompanied by a hypercoagulable state. While hepatic dysfunction in Fontan patients is common, its relationship with haemostatic changes and clinical outcomes in this patient population remains unclear ...
Paul Monagle, Vera Ignjatovic, David Winlaw, Thomas L Gentles, Karin du Plessis, Yves d'Udekem, Johannes Breur, Joelle Julius Nicolaas Daems, Chantal Attard, Suelyn Van Den Helm, Thomas G Wilson   +10 more
doaj   +1 more source

Prognostic Value of Liver and Spleen Stiffness in Patients with Fontan Associated Liver Disease (FALD): A Case Series with Histopathologic Comparison

Journal of Cardiovascular Development and Disease, 2021
The Fontan operation is the current surgical procedure to treat single-ventricle congenital heart disease, by splitting the systemic and pulmonary circulations and thus permitting lifespan to adulthood for the majority of newborns. However, emerging data
Massimo A. Padalino, Liliana Chemello, Luisa Cavalletto, Annalisa Angelini, Marny Fedrigo   +4 more
doaj   +1 more source

Abdominal imaging findings in adult patients with Fontan circulation

Insights into Imaging, 2018
The Fontan procedures, designed to treat paediatric patients with functional single ventricles, have markedly improved the patient’s survival into adulthood.
Tae-Hyung Kim, Hyun Kyung Yang, Hyun-Jung Jang, Shi-Joon Yoo, Korosh Khalili, Tae Kyoung Kim   +5 more
doaj   +1 more source

Selective Use of Pulmonary Vasodilators in Patients with Fontan Physiology

Journal of Interventional Cardiology, 2022
Background. Fontan-associated liver disease is a well-known sequela following the Fontan procedure for patients living with single-ventricle heart disease.
Thomas Glenn, Nicole Duster, Jerry Dwek, Jose Silva-Sepulveda, Howaida G. El-Said   +4 more
doaj   +1 more source

Transient liver elastography in the follow-up of Fontan patients: results of a nation wide survey in Germany

Frontiers in Pediatrics, 2023
IntroductionFontan-palliated patients are at risk for the development of Fontan-associated liver disease (FALD). Currently, there is no consensus on how to stage FALD.
Zora Meyer, Nikolaus Haas, Richard Mühlberg, Annabell Braun, Markus Fischer, Guido Mandilaras   +5 more
doaj   +1 more source

Morphologic Alterations Precede Functional Hepatic Impairment as Determined by 13C-Methacetin Liver Function Breath Test in Adult Fontan Patients

Frontiers in Cardiovascular Medicine, 2021
Objectives: Fontan-associated liver disease (FALD) is the most common end-organ dysfunction affecting up to 70–80% of the Fontan population. The clinical significance of FALD is incompletely understood and no unambiguous correlation between hepatic ...
Anastasia Schleiger, Peter Kramer, Hannes Sallmon, Niklas Jentsch, Marta Pileckaite, Friederike Danne, Marie Schafstedde, Marie Schafstedde, Marie Schafstedde, Hans-Peter Müller, Tobias Müller, Frank Tacke, Maximilian Jara, Martin Stockmann, Felix Berger, Felix Berger, Felix Berger, Stanislav Ovroutski   +17 more
doaj   +1 more source

Fontan‐associated liver disease: Monitoring progression of liver fibrosis [PDF]

Clinical Liver Disease, 2018
FALD continues to attract much research interest as complications affecting patient morbidity and mortality become increasingly apparent. Currently, there are still no official guidelines for monitoring this population, and multicenter cohort studies have only been published within the past year.1 Guidelines are institution dependent (Fig.
Tamir, Diamond, Nadia, Ovchinsky
openaire   +2 more sources

MicroRNA-29b/c-3p Indicate Advanced Liver Fibrosis/Cirrhosis in Univentricular Heart Patients With and Without Fontan Palliation

Frontiers in Cardiovascular Medicine, 2021
Aim: The present study aims to identify those microRNAs (miRNAs) in patients with univentricular heart (UVH) disease with and without Fontan palliation that may be associated with advanced liver fibrosis/cirrhosis.Materials and Methods: SurePrint™ 8 ...
Masood Abu-Halima, Masood Abu-Halima, Eckart Meese, Mohamad Ali Saleh, Andreas Keller, Hashim Abdul-Khaliq, Tanja Raedle-Hurst   +6 more
doaj   +1 more source

Alcohol use is prevalent among adults with the fontan circulation but does not correlate with liver disease

International Journal of Cardiology Congenital Heart Disease, 2022
Background: Alcohol consumption is associated with an increased risk of liver disease. There are limited studies on the epidemiology of alcohol use and its effects on Fontan-associated liver disease (FALD) in adulthood.
Shravani Chintakindi, Bendelyn Asante Boateng, Irine Vodkin, Nicole Herrick, Maria Moceri, Deborah Raleigh, Edward Wang, Howaida El-Said, Ryan Reeves, Jose Silva Sepulveda, Laith Alshawabkeh   +10 more
doaj   +1 more source